Fonte: European Journal of Medicinal Chemistry. Unidade: FCF
Assuntos: PLANEJAMENTO DE FÁRMACOS, LEISHMANIA
ABNT
LEITE, Franco Henrique Andrade et al. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. European Journal of Medicinal Chemistry, v. 132, p. 322-332, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2017.03.043. Acesso em: 11 out. 2024.APA
Leite, F. H. A., Froes, T. Q., Silva, S. G. da, Souza, E. I. M. de, Fujii, D. G. V., Trossini, G. H. G., et al. (2017). An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. European Journal of Medicinal Chemistry, 132, 322-332. doi:10.1016/j.ejmech.2017.03.043NLM
Leite FHA, Froes TQ, Silva SG da, Souza EIM de, Fujii DGV, Trossini GHG, Pita SS da R, Castilho MS. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors [Internet]. European Journal of Medicinal Chemistry. 2017 ; 132 322-332.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.ejmech.2017.03.043Vancouver
Leite FHA, Froes TQ, Silva SG da, Souza EIM de, Fujii DGV, Trossini GHG, Pita SS da R, Castilho MS. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors [Internet]. European Journal of Medicinal Chemistry. 2017 ; 132 322-332.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.ejmech.2017.03.043